Cognitive impairment is associated with altered blood cell profiles in aggressive lymphoma
Cognitive impairment was associated with blood cell parameters in individuals with aggressive lymphoma, indicating distinct biological patterns of dysfunction before, during, and after chemotherapy. The disconnect between objective neuropsychological performance and subjective self-reports reinforces the value of incorporating biomarkers into cognitive assessments in this population.
Authors
- Adam K. Walker (ORCID: https://orcid.org/0000-0001-7954-5801)
- Carlene J. Wilson (ORCID: https://orcid.org/0000-0002-1883-4690)
- Priscilla Gates (ORCID: https://orcid.org/0000-0002-7978-5802)
- Janette L. Vardy
- Haryana M. Dhillon
- Delyse McCaffrey
- Cynthia Shannon Weickert
Institutions
- The University of Sydney (AU)
- Deakin University (AU)
- SUNY Upstate Medical University (US)
- Concord Repatriation General Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- UNSW Sydney (AU)
- Cooperative Trials Group for Neuro-Oncology (AU)
- Austin Health (AU)
- Monash University (AU)
- Neuroscience Research Australia (AU)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2026-01-23
- DOI
- https://doi.org/10.1007/s00520-026-10317-6
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00